Stories
Slash Boxes
Comments

SoylentNews is people

posted by janrinok on Friday January 05 2018, @11:06PM   Printer-friendly
from the good-news-week dept.

Researchers are closing in on a non-addictive opiod-based pain-killer with limited side effects:

[...] [An] international team [has] captured the crystal structure of the kappa opioid receptor—critical for providing pain relief—in action on the surface of human brain cells. The researchers also made another important discovery: a new opioid-based compound that, unlike current opioids, activates only the kappa opioid receptor, raising hopes that they may develop a painkiller that has no risk of addiction and, therefore, none of the devastating consequences and side effects that accompany it.

The findings were published Jan. 4 in the journal Cell.

[...] Currently, most opioids bind to several opioid receptors on the membrane of brain cells, which has its share of drawbacks. They alleviate pain but cause a range of side effects, from nausea to numbness, constipation, anxiety, severe dependency, hallucinations and even death by respiratory depression.

In this study, the computer models revealed the formulations that would create the strongest bond between the ligand and the kappa opioid receptor without affecting other receptors.

Katritch said the latest research may pave the way for a major drug breakthrough.

"We have already found the structure of the inactive kappa opioid receptor highly useful for discovering potential candidates for a new painkiller," Katritch said. "Now with the structure of the active receptor, we have a template for designing new types of pain medications that have no disruptive side effects for patients and would reduce the burden that opioid addiction has placed on society."

Journal reference: Tao Che et al. Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor, Cell (2018). DOI: 10.1016/j.cell.2017.12.011

Having known several people who got addicted to painkillers after receiving prescriptions for oxycodone or similar compounds from their doctors, this can't happen soon enough.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by VLM on Saturday January 06 2018, @03:25PM

    by VLM (445) on Saturday January 06 2018, @03:25PM (#618774)

    I was bored and did some google searches

    https://www.statista.com/statistics/322991/sales-of-otc-pain-relief-products-in-the-us/ [statista.com]

    Seems to imply half the total OTC painkiller revenue in the USA in 2014 was Advil. Just advil. I had no idea it was that popular. Anyway insert tons of handwaving about bar graph interpretation and I'd say its not ridiculous to claim they scored $2B of revenue off non-addicting painkillers.

    http://theweek.com/articles/541564/how-american-opiate-epidemic-started-by-pharmaceutical-company [theweek.com]

    Seems to imply reading between the lines that the revenue for Oxy pills alone was $3B around the same time.

    Its a weak claim, but the markets being similar ish in size would imply it would be no big deal to essentially transfer the entire existing addictive pain pill market into the existing OTC pain pill market.

    Of course OTC aspirin tylenol advil gets taken for non-pain reasons, possibly mostly for non-pain reasons like fever reduction.

    Just saying its not economically or logistically ridiculous to see something merely a couple times bigger in total sales than Advil being sold OTC at your local pharmacy.

    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2